https://www.selleckchem.com/pr....oducts/MGCD0103(Moce
lts of the present study indicated that the RvD1-ALX/FPR2 interaction could potentially play dual roles in the CNS, as inhibiting Hb promoted microglial pro-inflammatory polarization and ameliorating Hb induced neuronal oxidant damage and death. These results shed light on a good therapeutic target (ALX/FPR2) and a potential effective drug (RvD1) for the treatment of SAH and other inflammation-associated brain diseases. Patients with resected oral cavity squamous cell carcinoma (OCSCC) are often treated with adjuvant radi
Beğen
Yorum Yap
Paylaş
